arrow
A

Adam E. Frampton

University of Surrey
H指数:47
被引数:6,087

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Surgical Outcomes in Gallbladder Cancer: Evidence from the UK Nationwide CAPBIL Study

胆囊癌的手术治疗结果:来自英国全国CAPBIL研究的证据

HPB
IF2.4
2026-06-220
PRE
Age, patient experience and satisfaction with breast cancer care: a cohort study using linked national cancer patient experience survey and cancer registry data

年龄、患者经历及对乳腺癌护理的满意度:一项使用关联国家癌症患者经历调查和癌症登记数据的队列研究

2026-05-120
PRE
A pre-operative two-week very low-calorie diet to reduce steatosis before liver resection (RESOLVE): A multi-centre randomised controlled feasibility trial

术前两周极低热量饮食以减少肝切除术前的脂肪变性(RESOLVE):一项多中心随机对照可行性试验

2026-03-020
PRE
Adherence to Best Practice Guidelines for the Management of Intrahepatic Cholangiocarcinoma: Results from the Capbil Study
bjs
IF0
2026-01-230
PRE
Control of Antibody Orientation on Graphene Using Porphyrin Linker Molecules for High-Performance Graphene-Based Immuno-Biosensors

利用卟啉连接分子控制抗体在石墨烯上的取向,用于高性能石墨烯基免疫生物传感器

2025-12-090
PRE
The E-AHPBA – ESSO – Innsbruck consensus recommendations on peri- and postoperative management following liver resection

E-AHPBA – ESSO – Innsbruck关于肝切除术后围手术期及术后管理的共识建议

HPB
IF2.4
2025-11-130
OAAI
PERI-HILAR CHOLANGIOCARCINOMA: RESULTS FROM THE UK NATIONWIDE CAPBIL STUDY

周围肝门胆管癌:来自英国全国CAPBIL研究的结果

HPB
IF2.4
2025-08-220
PRE
Prehabilitation during neoadjuvant chemotherapy results in an enhanced immune response in esophageal adenocarcinoma tumors: A randomized controlled trial

新辅助化疗期间进行围手术期准备可增强食管腺癌肿瘤的免疫反应:一项随机对照试验

2025-06-090
OAAI
A multi-centre, UK-based, cohort study assessing the role of robotic common bile duct exploration for complex choledocholithiasis

一项多中心、英国基于的队列研究,评估机器人胆总管探查术在复杂胆总管结石中的作用

HPB
IF2.4
2025-05-280
PRE
Safety of Robotic cholecystectomy as index training procedure - the UK experience
2024-11-130
PRE
The microbial composition of pancreatic ductal adenocarcinoma: a systematic review of 16S rRNA gene sequencing

胰腺导管腺癌的微生物组成: 16s rRNA基因测序的系统评价

2024-10-011
OAAI
MicroRNAs as Bile-based biomarkers in pancreaticobiliary cancers (MIRABILE): a cohort study
2024-10-011
OAAI
Unlocking the diagnostic power of plasma extracellular vesicle miR-200 family in pancreatic ductal adenocarcinoma
2024-07-080
OAAI